These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma. Suwanrusme H; Meyer ML; Green MR Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S56-60. PubMed ID: 15117426 [TBL] [Abstract][Full Text] [Related]
7. Standard therapy for the treatment of malignant pleural mesothelioma. Vogelzang NJ Lung Cancer; 2005 Oct; 50 Suppl 1():S23-4. PubMed ID: 16291429 [TBL] [Abstract][Full Text] [Related]
8. Emerging insights into the biology and therapy of malignant mesothelioma. Vogelzang NJ Semin Oncol; 2002 Dec; 29(6 Suppl 18):35-42. PubMed ID: 12571809 [TBL] [Abstract][Full Text] [Related]
9. Pemetrexed in malignant pleural mesothelioma. Hazarika M; White RM; Booth BP; Wang YC; Ham DY; Liang CY; Rahman A; Gobburu JV; Li N; Sridhara R; Morse DE; Lostritto R; Garvey P; Johnson JR; Pazdur R Clin Cancer Res; 2005 Feb; 11(3):982-92. PubMed ID: 15709163 [TBL] [Abstract][Full Text] [Related]
10. Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma. Jänne PA; Simon GR; Langer CJ; Taub RN; Dowlati A; Fidias P; Monberg M; Obasaju C; Kindler H J Clin Oncol; 2008 Mar; 26(9):1465-71. PubMed ID: 18349397 [TBL] [Abstract][Full Text] [Related]
11. ERCC1 as a biological marker guiding management in malignant pleural mesothelioma. Cihan YB; Ozturk A; Arslan A; Deniz K; Baran M; Karaca H Asian Pac J Cancer Prev; 2014; 15(10):4117-23. PubMed ID: 24935356 [TBL] [Abstract][Full Text] [Related]
13. Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients. Shukuya T; Takahashi T; Imai H; Tokito T; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Yamamoto N Respir Investig; 2014 Mar; 52(2):101-6. PubMed ID: 24636265 [TBL] [Abstract][Full Text] [Related]
14. Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed. Agatsuma T; Koizumi T; Yasuo M; Urushihata K; Tsushima K; Yamamoto H; Hanaoka M; Fukushima M; Honda T; Kubo K Jpn J Clin Oncol; 2010 Dec; 40(12):1180-3. PubMed ID: 20603247 [TBL] [Abstract][Full Text] [Related]
15. Can pemetrexed help in malignant mesothelioma? Drug Ther Bull; 2006 Oct; 44(10):77-80. PubMed ID: 17067119 [TBL] [Abstract][Full Text] [Related]
16. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer. Le Chevalier T Semin Oncol; 2003 Aug; 30(4 Suppl 10):37-44. PubMed ID: 12947960 [TBL] [Abstract][Full Text] [Related]
17. The emerging role of antifolates in the treatment of malignant pleural mesothelioma. Fizazi K; John WJ; Vogelzang NJ Semin Oncol; 2002 Feb; 29(1):77-81. PubMed ID: 11836672 [TBL] [Abstract][Full Text] [Related]
18. Pemetrexed: new drug. Pleural mesothelioma: a first encouraging trial. Prescrire Int; 2005 Dec; 14(80):212-4. PubMed ID: 16400741 [TBL] [Abstract][Full Text] [Related]
19. The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review. Boons CC; VAN Tulder MW; Burgers JA; Beckeringh JJ; Wagner C; Hugtenburg JG Anticancer Res; 2013 Sep; 33(9):3553-61. PubMed ID: 24023280 [TBL] [Abstract][Full Text] [Related]
20. Pemetrexed-cisplatin combination in mesothelioma. Reck M; Gatzemeier U Expert Rev Anticancer Ther; 2005 Apr; 5(2):231-7. PubMed ID: 15877521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]